GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IMGT Corp Ltd (XKRX:456570) » Definitions » Treasury Stock

IMGT (XKRX:456570) Treasury Stock : ₩0.00 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is IMGT Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. IMGT's treasury stock for the quarter that ended in Dec. 2023 was ₩0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

IMGT Treasury Stock Historical Data

The historical data trend for IMGT's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMGT Treasury Stock Chart

IMGT Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Treasury Stock
- - - -

IMGT Semi-Annual Data
Dec20 Dec21 Dec22 Dec23
Treasury Stock - - - -

IMGT Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

IMGT Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IMGT Corp Ltd (XKRX:456570) » Definitions » Treasury Stock
Comparable Companies
XKRX:036480 XKRX:208340 XKRX:115180 XKRX:344860 XKRX:383930 XKRX:298060 XKRX:065650 XKRX:299660 XKRX:179530 XKRX:142760 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
172 Dolma-ro,, 408, Healthcare Innovation Park, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13605
Website
http://www.imgt.co.kr
IMGT Corp Ltd develops a focused ultrasound-based drug delivery platform for intractable diseases. It is developing nanomedicines and focused ultrasound medical devices that respond to focused ultrasound. The firm has two pipeline products IMD20 and IMP101. IMD20 is a FUS device developed for chronic pain as a product with reduced size and output from IMD10 developed for cancer treatment. IMP101 is a nanoparticle used for hepatocarcinoma embolization.

IMGT Headlines

No Headlines